Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'CALIFF RM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 579 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shah, MR; Hasselblad, V; Stinnett, SS; Gheorghiade, M; Swedberg, K; Califf, RM; O'Connor, CM
      Hemodynamic profiles of advanced heart failure: Association with clinical characteristics and long-term outcomes

      JOURNAL OF CARDIAC FAILURE
    2. Alexander, KP; Newby, LK; Hellkamp, AS; Harrington, RA; Peterson, ED; Kopecky, S; Langer, A; O'Gara, P; O'Connor, CM; Daly, RN; Califf, RM; Khan, S; Fuster, V
      Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    3. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P
      ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) (vol 36, pg 970, 2000)

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    4. Anderson, KM; Califf, RM; Stone, GW; Neumann, FJ; Montalescot, G; Miller, DP; Ferguson, JJ; Willerson, JT; Weisman, HF; Topol, EJ
      Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    5. Cantor, WJ; Hellkamp, AS; Peterson, ED; Zidar, JP; Cowper, PA; Sketch, MH; Tcheng, JE; Califf, RM; Ohman, EM
      Achieving optimal results with standard balloon angioplasty: Can baseline and angiographic variables predict stent-like outcomes?

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    6. Bahit, MC; Topol, EJ; Califf, RM; Armstrong, PW; Criger, DA; Hasselbad, V; Betriu, A; Hirsh, J; Ardissino, D; Granger, CB
      Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb. (vol 37, pg 1001, 2001)

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    7. Bahit, MC; Topol, EJ; Califf, RM; Armstrong, PW; Criger, DA; Hasselblad, V; Betriu, A; Hirsh, J; Ardissino, D; Granger, CB
      Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    8. Greenbaum, AB; Harrington, RA; Hudson, MP; MacAulay, CM; Wilcox, RG; Simoons, ML; Berdan, LG; Guerci, A; Cokkinos, DV; Kitt, MM; Lincoff, AM; Topol, EJ; Califf, RM; Ohman, EM
      Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    9. Roe, MT; Ohman, EM; Maas, ACP; Christenson, RH; Mahaffey, KW; Granger, CB; Harrington, RA; Califf, RM; Krucoff, MW
      Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    10. DeLong, ER; Nelson, CL; Wong, JB; Pryor, DB; Peterson, ED; Lee, KL; Mark, DB; Califf, RM; Pauker, SG
      Using observational data to estimate prognosis: an example using a coronary artery disease registry

      STATISTICS IN MEDICINE
    11. White, HD; Simes, RJ; Aylward, PEG; Armstrong, PW; Califf, RM; French, JK; Granger, CB; Marschner, IC; Topol, EJ; Van de Werf, FJ; Wilcox, RG
      Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial

      LANCET
    12. Topol, EJ; Califf, RM; Van de Werf, F; Willerson, JT; Booth, J; White, H; Clayman, M; Deckelbaum, L; Lincoff, AM; Ohman, EM; Bates, E; Gibler, WB; Hochman, J; Kleiman, N; Grinfeld, L; Aylward, P; Armstrong, PW; Heikkila, J; Vahanian, A; Steg, G; Bode, C; Adgy, AAJ; Guetta, V; Ardissino, D; Savonitto, S; Bar, F; Simoons, M; Kontny, F; White, H; Sadowski, Z; Seabra-Gomes, R; Dalby, A; Betriu, A; Swahn, E; Wilcox, R; Frye, RL; Bertrand, ME; DeMets, D; Fox, KKA; Fuster, V; Lee, KL; McCarthy, C; Waller, M; Scherer, J; van de Kerkhove, A; Kukulewicz, L; Booth, JE; Del Valle, M; Hibert, D; Brannon, D
      Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial

      LANCET
    13. Aronow, HD; Topol, EJ; Roe, MT; Houghtaling, PL; Wolski, KE; Lincoff, AM; Harrington, RA; Califf, RM; Ohman, EM; Kleiman, NS; Keltai, M; Wilcox, RG; Vahanian, A; Armstrong, PW; Lauer, MS
      Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

      LANCET
    14. Akkerhuis, KM; Deckers, JW; Lincoff, AM; Tcheng, JE; Boersma, E; Anderson, K; Balog, C; Califf, RM; Topol, EJ; Simoons, ML
      Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    15. Morse, MA; Califf, RM; Sugarman, J
      Monitoring and ensuring safety during clinical research

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    16. Morse, MA; Califf, RM; Sugarman, J
      The role of local institutional review boards in protecting human researchsubjects - Reply

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    17. Al-Khatib, SMN; Califf, RM; Hasselblad, V; Alexander, JH; McCrory, DC; Sugarman, J
      Short-term trials and long-term effects - Response

      SCIENCE
    18. Al-Khatib, SM; Califf, RM; Hasselblad, V; Alexander, JH; McCrory, DC; Sugarman, J
      Medicine - Placebo-controls in short-term clinical trials of hypertension

      SCIENCE
    19. Hudson, MP; Granger, CB; Topol, EJ; Pieper, KS; Armstrong, PW; Barbash, GI; Guerci, AD; Vahanian, A; Califf, RM; Ohman, EM
      Early reinfarction after fibrinolysis - Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (Alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies to Open occluded coronary arteries (GUSTO III) trials

      CIRCULATION
    20. Barbash, GI; Birnbaum, Y; Bogaerts, K; Hudson, M; Lesaffre, E; Fu, YL; Goodman, S; Houbracken, K; Munsters, K; Granger, CB; Pieper, K; Califf, RM; Topol, EJ; Van de Werf, F
      Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies

      CIRCULATION
    21. Newby, LK; Ohman, EM; Christenson, RH; Moliterno, DJ; Harrington, RA; White, HD; Armstrong, PW; Van de Werf, F; Pfisterer, M; Hasselblad, V; Califf, RM; Topol, EJ
      Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status - The PARAGON-B troponin T substudy

      CIRCULATION
    22. Jiang, W; Alexander, J; Christopher, E; Kuchibhatla, M; Gaulden, LH; Cuffe, MS; Blazing, MA; Davenport, C; Califf, RM; Krishnan, RR; O'Connor, CM
      Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure

      ARCHIVES OF INTERNAL MEDICINE
    23. Shah, MR; Hasselblad, V; Gheorghiade, M; Adams, KF; Swedberg, K; Califf, RM; O'Connor, CM
      Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy

      AMERICAN JOURNAL OF CARDIOLOGY
    24. Birnbaum, Y; Goodman, S; Barr, A; Gates, KB; Barbash, GI; Battler, A; Barbagelata, A; Clemmensen, P; Sgarbossa, EB; Granger, CB; Califf, RM; Wagner, GS
      Comparison of primary coronary angioplasty versus thrombolysis in patientswith ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram

      AMERICAN JOURNAL OF CARDIOLOGY
    25. O'Connor, CM; Gattis, WA; Hellkamp, AS; Langer, A; Larsen, RL; Harrington, RA; Berkowitz, SD; O'Gara, PT; Kopecky, SL; Gheorghiade, M; Daly, R; Califf, RM; Fuster, V
      Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)

      AMERICAN JOURNAL OF CARDIOLOGY
    26. Tcheng, JE; Talley, JD; O'Shea, JC; Gilchrist, IC; Kleiman, NS; Grines, CL; Davidson, CJ; Lincoff, AM; Califf, RM; Jennings, LK; Kitt, MM; Lorenz, TJ
      Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study)

      AMERICAN JOURNAL OF CARDIOLOGY
    27. Al-Khatib, SM; Pieper, KS; Lee, KL; Mahaffey, KW; Hochman, JS; Pepine, CJ; Kopecky, SL; Akkerhuis, M; Stepinska, J; Simoons, ML; Topol, EJ; Califf, RM; Harrington, RA
      Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: Results from the PURSUIT trial

      AMERICAN JOURNAL OF CARDIOLOGY
    28. Mast, ST; Gersing, KR; Anstrom, KJ; Krishnan, KR; Califf, RM; Jollis, JG
      Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation

      AMERICAN JOURNAL OF CARDIOLOGY
    29. Peterson, JG; Topol, EJ; Roe, MT; Sapp, SK; Lincoff, AM; Deckers, JW; Blackstone, EH; Harrington, RA; Califf, RM; Lauer, MS
      Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes

      AMERICAN JOURNAL OF CARDIOLOGY
    30. Donahue, M; Fuster, V; Califf, RM
      Introduction: Cardiologists should target obesity

      AMERICAN HEART JOURNAL
    31. Kandzari, DE; Lam, LC; Eisenstein, EL; Clapp-Channing, N; Fine, JT; Califf, RM; Mark, DB; Jollis, JG
      Advanced coronary artery disease: Appropriate end points for trials of novel therapies

      AMERICAN HEART JOURNAL
    32. Blazing, MA; de Lemos, JA; Dyke, CK; Califf, RM; Bilheimer, D; Braunwald, E
      The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

      AMERICAN HEART JOURNAL
    33. Lundergan, CF; Ross, AM; McCarthy, WF; Reiner, JS; Boyle, D; Fink, C; Califf, RM; Topol, EJ; Simoons, ML; Van Den Brand, M; Van de Werf, F; Coyne, KS
      Predictors of left ventricular function after acute myocardial infarction:Effects of time to treatment potency, and body mass index - The GUSTO-I angiographic experience

      AMERICAN HEART JOURNAL
    34. Whellan, DJ; Shaw, LK; Bart, BA; Kraus, WE; Califf, RM; O'Connor, CM
      Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction

      AMERICAN HEART JOURNAL
    35. Shah, MR; Stinnett, SS; McNulty, SE; Gheorghiade, M; Zannad, F; Uretsky, B; Adams, KF; Califf, RM; O'Connor, CM
      Hemodynamics as surrogate end points for survival in advanced heart failure: An analysis from FIRST

      AMERICAN HEART JOURNAL
    36. O'Shea, JC; Califf, RM
      Results of Expert Meetings: International differences in cardiovascular clinical trials - Barcelona, Spain - August 25-26, 1999 - Introduction

      AMERICAN HEART JOURNAL
    37. O'Shea, JC; Califf, RM
      International differences in cardiovascular clinical trials

      AMERICAN HEART JOURNAL
    38. O'Shea, JC; Califf, RM
      International differences in treatment effects in cardiovascular clinical trials

      AMERICAN HEART JOURNAL
    39. Shah, MR; O'Connor, CM; Sopko, G; Hasselblad, V; Califf, RM; Stevenson, LW
      Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): Design and rationale

      AMERICAN HEART JOURNAL
    40. Cohen, MG; Pacchiana, CM; Corbalan, R; Perez, JEI; Ponte, CI; Oropeza, ES; Diaz, R; Paolasso, E; Izasa, D; Rodas, MA; Urrutia, CE; Harrington, RA; Topol, EJ; Califf, RM
      Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial

      AMERICAN HEART JOURNAL
    41. Labinaz, M; Sketch, MH; Ellis, SG; Abramowitz, BM; Stebbins, AL; Pieper, KS; Holmes, DR; Califf, RM; Topol, EJ
      Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy

      AMERICAN HEART JOURNAL
    42. Califf, RM; Ellenberg, SS
      Statistical approaches and policies for the operations of Data and Safety Monitoring Committees

      AMERICAN HEART JOURNAL
    43. Califf, RM; Lee, KL
      Data and safety monitoring committees: Philosophy and practice - Introduction

      AMERICAN HEART JOURNAL
    44. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P; Gibbons, RMJ; Alpert, JS; Eagle, KA; Faxon, DP; Fuster, V; Gardner, TJ; Gregoratos, G; Russell, RO; Smith, SC
      ACC/AHA guidelines for the management of patients with unstable angina andnon-ST segment elevation myocardial infarction: Executive summary and recommendations

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    45. Califf, RM
      State of the art: ACS treatment at the turn of the century

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    46. Eisenstein, EL; Peterson, ED; Jollis, JG; Tardiff, BE; Califf, RM; Knight, JD; Mark, DB
      Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome

      PHARMACOECONOMICS
    47. Kleiman, NS; Tracy, RP; Talley, JD; Sigmon, K; Joseph, D; Topol, EJ; Califf, RM; Kitt, M; Ohman, EM
      Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonistdoes not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    48. Chang, WC; Fu, YL; Ohman, EM; Gupta, M; Morris, A; Roth, SN; Granger, CB; Califf, RM; Topol, EJ; Mark, DB; Armstrong, PW
      Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States

      CANADIAN JOURNAL OF CARDIOLOGY
    49. Auerbach, AD; Hamel, MB; Califf, RM; Davis, RB; Wenger, NS; Desbiens, N; Goldman, L; Vidaillet, H; Connors, AF; Lynn, J; Dawson, NV; Phillips, RS
      Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    50. Herrmann, HC; Moliterno, DJ; Ohman, EM; Stebbins, AL; Bode, C; Betriu, A; Forycki, F; Miklin, JS; Bachinsky, WB; Lincoff, AM; Califf, RM; Topol, EJ
      Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction - Results from the SPEED (GUSTO-4 pilot) trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    51. Hasdai, D; Harrington, RA; Hochman, JS; Califf, RM; Battler, A; Box, JW; Simoons, ML; Deckers, J; Topol, EJ; Holmes, DR
      Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    52. Goodman, SG; Cohen, M; Bigonzi, F; Gurfinkel, EP; Radley, DR; Le Iouer, V; Fromell, GJ; Demers, C; Turpie, AGG; Califf, RM; Fox, KAA; Langer, A
      Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    53. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P; Gibbons, RJ; Alpert, JS; Eagle, KA; Faxon, DP; Fuster, V; Gardner, TJ; Gregoratos, G; Russell, RO; Smith, SC
      ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    54. Hasdai, D; Granger, CB; Srivatsa, SS; Criger, DA; Ellis, SG; Califf, RM; Topol, EJ; Holmes, DR
      Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy (vol 35, pg 1502, 2000)

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    55. Sane, DC; Damaraju, LV; Topol, EJ; Cabot, CF; Mascelli, MA; Harrington, RA; Simoons, ML; Califf, RM
      Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    56. Kleiman, NS; Califf, RM
      Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    57. Hasdai, D; Granger, CB; Srivatsa, SS; Criger, DA; Ellis, SG; Califf, RM; Topol, EJ; Holmes, DR
      Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    58. Lincoff, AM; Califf, RM; Topol, EJ
      Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    59. Alderman, EL; Brooks, MM; Bourassa, M; Califf, RM; Chaitman, BR; Detre, K; Faxon, D; Frye, R; Hardison, RM; Hlatky, M; Holubkov, R; Jones, RH; Kelsey, SF; Schaff, H; Shemin, RJ; Sopko, G; Sutton-Tyrrell, K; Williams, DO
      Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    60. Shah, A; Wagner, GS; Granger, CB; O'Connor, CM; Green, CL; Trollinger, KM; Califf, RM; Krucoff, MW
      Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis - Reexamining the "gold standard" for myocardial reperfusion assessment

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    61. Hasdai, D; Califf, RM; Thompson, TD; Hochman, JS; Ohman, EM; Pfisterer, M; Bates, ER; Vahanian, A; Armstrong, PW; Criger, DA; Topol, EJ; Holmes, DR
      Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    62. Akkerhuis, KM; Deckers, JW; Boersma, E; Harrington, RA; Stepinska, J; Mahaffey, KW; Wilcox, RG; Lincoff, AM; Keltai, M; Topol, EJ; Califf, RM; Simoons, ML
      Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT

      EUROPEAN HEART JOURNAL
    63. Menon, V; Hochman, JS; Stebbins, A; Pfisterer, M; Col, J; Anderson, RD; Hasdai, D; Holmes, DR; Bates, ER; Topol, EJ; Califf, RM; Ohman, EM
      Lack of progress in cardiogenic shock: lessons from the GUSTO trials

      EUROPEAN HEART JOURNAL
    64. McGuire, DK; Emanuelsson, H; Granger, CB; Ohman, EM; Moliterno, DJ; White, HD; Ardissino, D; Box, JW; Califf, RM; Topol, EJ
      Influence of diabetes mellitus on clinical outcomes across the spectrum ofacute coronary syndromes - Findings from the GUSTO-IIb Study

      EUROPEAN HEART JOURNAL
    65. O'Shea, JC; Califf, RM
      Inter-regional differences in acute coronary syndrome trials

      EUROPEAN HEART JOURNAL
    66. Dyke, CK; Califf, RM
      National and regional registries: what good are they?

      EUROPEAN HEART JOURNAL
    67. Tcheng, JE; O'Shea, JC; Cohen, EA; Pacchiana, CM; Kitt, MM; Lorenz, TJ; Greenberg, S; Strony, J; Califf, RM; Buller, C; Cantor, WJ; Joseph, DM; Kitt, MM; Lincoff, AM; Madan, M; Popma, J; Teirstein, P; Cohen, E; Balleza, L; Parsons, P; Lui, H; Young, J; Fox, R; Labinaz, M; Jelley, J; Williams, J; Cohen, D; Trovato, M; Smith, J; Henry, P; Chisholm, R; O'Donnell, D; Talley, JD; Pacheco, R; Timmis, S; Muraka, A; Mann, T; Cubeddu, G; Tannenbaum, M; Greene, J; Santoian, E; Wash, M; Sheldon, S; Pronesti, L; Jain, A; Alonzo, M; Seidelin, P; Richards, J; Lopez, M; Dittenber, R; Johnson, K; Levine, G; Maresh, K; Ferrando, T; Sarembock, I; Snyder, L; Kieval, J; Herlan, L; Miller, M; Bembridge, D; Nair, R; Hickel, L; Kiernan, F; Murphy, D; Cloutier, J; Conn, E; Beardsley, J; Ritchie, M; Cragen, D; Jafar, MZ; Counihan, P; Rosenfelder, D; Ducas, J; Montebruno, L; Carere, R; Radons, B; Williams, L; Owens, W; Dougal, R; Feldman, R; Audrain, D; Karamali, A; Smith, M; Blankenship, J; Demko, SL; Thompson, M; Gacoich, G; Chiodo, V; Noll, P; Ledley, G; Miller, C; Felten, W; Garner, B; Chandler, AB; Easler, P; Albin, G; Page, A; Maddox, W; Allen, S; Gilchrist, I; Moore, R; Zimmerman, H; Curtis, M; Hildebrand, K; Greene, R; Healy, E; Meengs, W; Carson, D; George, J; Roncevich, T; Aharonian, V; Browning, R; Kostuk, W; Carr, S; Feit, F; Gostomsky, B; Butman, S; Hannah, E; Hassel, CD; Hartley, D; Shook, T; Hiller-Mullin, S; Brill, D; Dillion, M; Armstrong, B; Kerns, D; Pichard, A; Okubagzi, P; Nasser, T; Driver, L; Garrett, J; Boltey, L; Stouffer, G; Potter, M; Amidon, T; Eggert, S; Taussig, A; Potter, K; Natarajan, M; Tartaglia, C; Werner, J; Dunlap, T; Harrold-Runge, P; Davidson, C; Goodreau, L; Herzog, W; Calamunci, N; Slater, A; Tormey, D; Phillips, W; White, D; Sridhar, K; White, J; Goodman, D; Buchbinder, M; Nasser, V; Rapeport, K; Vorman, P; Weiner, B; Borbone, M; Shadoff, N; Paap, C; Rehman, A; Haag, E; Burchenal, J; Kioussopoulos, K; Senior, D; Senior, J; Piana, R; Kirshenbaum, J; Chan, S; Chowdry, A; Kraft, P; Clark, V; Fox, M; Deutsch, E; Shannon, T; Quesada, R; Brotherton, J; Murrin, C; Cinderella, J; Hearne, S; Seefried, V; Farah, T; Pakstis, D; Bartolet, B; Bond, C; Debarardinis, C; Montory, D; Smith, G; Gray, D; Phillips, P; Hathaway, S; Manoukian, S; Patrick, C; Yakubov, S; Brooks, J; Block, P; Block, B; Muhlestein, JB; Kim, S; Shalev, Y; Schmidt, W; Resar, J; Citro, K; Stine, R; Zumbuhl, J; Moreyra, A; Kreiger, S; Berger, P; Cannon, CP; Fisher, L; Hasselblad, V; Foster, A; Joseph, D; Madan, M; McLendon, C; Rund, M; Tillery, N; Wood, F; Mahaffey, KW; Irwin, C; Kulick, D; Johnson, N; Chen, J; Greenberg, S; Hogeboom, C; Lorenz, TJ; Terifay, R; Strony, J; Veltri, E
      Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

      LANCET
    68. Newby, LK; Bhapkar, MV; Lee, KL; Califf, RM
      Randomisation in the SYMPHONY trial - Reply

      LANCET
    69. Hasdai, D; Topol, EJ; Califf, RM; Berger, PB; Holmes, DR
      Cardiogenic shock complicating acute coronary syndromes

      LANCET
    70. Velazquez, EJ; Califf, RM
      All that glitters is not gold

      LANCET
    71. Topol, CE; Califf, RM; Simes, RJ; Van de Werf, F; Diaz, R; Paolasso, E; Aylward, PE; Keech, A; Klein, W; Piegas, L; Tomov, I; Armstrong, PW; Widimsky, P; Grande, P; Halinen, M; Vahanian, A; Neuhaus, K; Dimas, AP; Preda, I; Kristinsson, A; Tzivoni, D; Ardissino, D; White, HD; Madsen, S; Sugrue, D; Sadowski, Z; Seabra-Gomes, R; Apetrei, E; Dalby, A; Betriu, A; Pfisterer, M; Verheugt, F; Fox, K; Bates, ER; Gibler, WB; Granger, CB; Harrington, RA; Hochman, JS; Holmes, DR; Kleiman, NS; Lee, KL; Moliterno, DJ; Newby, LK; Ohman, EM; Califf, R; Newby, K; Zillman, L; Lee, K; Lemons, P; McCourt, B; Campbell, C; Tardiff, B; Snapp, J; Bassett, K; Hodgson, P; Hannan, K; Kandzari, L; Hawkins, S; Hinman-Smith, E; McDougal, M; Raffetto, K; Thompson, D; Wehrle, T; Ange, C; Brown, R; Grissom, G; Heuckel, M; McCall, J; Pennachi, W; Spychala, M; Veasey, S; Pullium, M; Journey, T; Quintero, K; Mark, D; Davidson-Ray, L; Diner, L; Nelson, C; Sowers, C; Webb, G; Young, M; Bhapkar, M; Pacchiana, C; Sparapani, R; Tuttle, R; Weaver, D; Borzak, S; Douthat, L; Topol, E; Moliterno, D; Konczos, L; Baishnab, R; Baishnab, R; Bakos, A; Blashford, L; Bratsch, J; Brown, K; Cadorini, E; Carlson, J; Clemmons, P; DelValle, M; Drabik, M; Fu, G; Gates, K; Gibson, Y; Heil, L; Hill, N; Klancar, R; McHale, B; Montague, E; Pasca, N; Pergi, L; Randall, R; Rosso, R; Sankovich, K; Smith, D; Wisniewski, L; Witkowski, M; Zovkic, V; Alexander, K; Bhatt, D; Brener, S; Campbell, L; Cho, L; Cole, C; Deedy, M; Foody, J; Gassler, J; Ghaffari, S; Haas, G; Kapadia, S; Lauer, M; Lauer, MS; Lincoff, M; Lutton, S; Marso, S; Mukherjee, D; Patel, V; Penn, M; Robbins, M; Roe, M; Sila, C; Thamilarasan, M; Wagner, G; Armstrong, P; Bestilny, S; Van de Werf, F; Budts, W; Graux, S; Luyten, A; Simes, J; Keech, A; Kava, M; Bower, T; Chan, S; Crampton, L; Monro, C; Nayak, M; Parente, G; Riley, V; Wilton, D; Aylward, P; Dolan, S; Thomas, C; White, H; Scott, M; Frye, R; Alpert, J; Bertrand, M; Ryan, T; Fisher, L; Asarch, L; Smith, M; Lim, L; Bokslag, M; Chiu, P; Chung, J; Collins, S; Dougherty, C; Guimaraes, D; Hakim, Z; Mathieson, J; Montgomery, L; Novotny, B; Steiner, B; Wittke, B
      Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial

      LANCET
    72. Alexander, JH; Sparapani, RA; Mahaffey, KW; Deckers, JW; Newby, LK; Ohman, EM; Corbalan, R; Chierchia, SL; Boland, JB; Simoons, ML; Califf, RM; Topol, EJ; Harrington, RA
      Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    73. Califf, RM; O'Connor, CM
      beta-blocker therapy for heart failure - The evidence is in, now the work begins

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    74. Newby, LK; Eisenstein, EL; Califf, RM; Thompson, TD; Nelson, CL; Peterson, ED; Armstrong, PW; Van de Werf, F; White, HD; Topol, EJ; Mark, DB
      Cost effectiveness of early discharge after uncomplicated acute myocardialinfarction.

      NEW ENGLAND JOURNAL OF MEDICINE
    75. Akkerhuis, KM; Maas, ACP; Klootwijk, PAJ; Krucoff, MW; Meij, S; Califf, RM; Simoons, ML
      Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction

      JOURNAL OF ELECTROCARDIOLOGY
    76. Harrington, RA; Armstrong, PW; Graffagnino, C; Van de Werf, F; Kereiakes, DJ; Sigmon, KN; Card, T; Joseph, DM; Samuels, R; Granett, J; Chan, R; Califf, RM; Topol, EJ
      Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease

      CIRCULATION
    77. Berger, PB; Criger, DA; Holmes, DR; Ellis, SG; Granger, CB; Betriu, A; Topol, EJ; Califf, RM
      Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction - Response

      CIRCULATION
    78. Lincoff, AM; Mark, DB; Tcheng, JE; Califf, RM; Bala, MV; Anderson, KM; Davidson-Ray, L; Knight, JD; Cabot, CF; Topol, EJ
      Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization - Results from the EPILOG randomized trial

      CIRCULATION
    79. Marso, SP; Bhatt, DL; Roe, MT; Houghtaling, PL; Labinaz, M; Kleiman, NS; Dyke, C; Simmoons, ML; Califf, RM; Harrington, RA; Topol, EJ
      Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting

      CIRCULATION
    80. Topol, EJ; Ohman, EM; Armstrong, PW; Wilcox, R; Skene, AM; Aylward, P; Simes, J; Dalby, A; Betriu, A; Bode, C; White, HD; Hochman, JS; Emanuelson, H; Vahanian, A; Sapp, S; Stebbins, A; Moliterno, DJ; Califf, RM
      Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction - Results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) IIItrial

      CIRCULATION
    81. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepin, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P; Gibbons, RJ; Alpert, JS; Eagle, KA; Faxon, DP; Fuster, V; Gardner, TJ; Gregoratos, G; Russell, RO; Smith, SC
      ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: Executive summary and recommendations - A report of the American College of Cardiology American HeartAssociation Task Force on Practice Guidelines (Committee on the Managementof Patients with Unstable Angina) (vol 102, pg 1193, 2000)

      CIRCULATION
    82. Califf, RM
      Cigarette smoking - How much worse can it get?

      CIRCULATION
    83. Fu, YL; Chang, WC; Mark, D; Califf, RM; Mackenzie, B; Granger, CB; Topol, EJ; Hlatky, M; Armstrong, PW
      Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial - One-year follow-up of patients without ST-segment elevation

      CIRCULATION
    84. Lincoff, AM; Harrington, RA; Califf, RM; Hochman, JS; Guerci, AD; Ohman, EM; Pepine, CJ; Kopecky, SL; Kleiman, NS; Pacchiana, CM; Berdan, LG; Kitt, MM; Simoons, ML; Topol, EJ
      Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition - Insights from the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial

      CIRCULATION
    85. Roe, MT; Harrington, RA; Prosper, DM; Pieper, KS; Bhatt, DL; Lincoff, AM; Simoons, ML; Akkerhuis, M; Ohman, EM; Kitt, MM; Vahanian, A; Ruzyllo, W; Karsch, K; Califf, RM; Topol, EJ
      Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease

      CIRCULATION
    86. Braunwald, E; Antman, EM; Beasley, JW; Califf, RM; Cheitlin, MD; Hochman, JS; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Steward, DE; Theroux, P; Gibbons, RJ; Alpert, JS; Eagle, KA; Faxon, DP; Fuster, V; Gardner, TJ; Gregoratos, G; Russell, RO; Smith, SC
      ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: Executive summary and recommendations - A report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines (Committee on the Managementof Patients with Unstable Angina)

      CIRCULATION
    87. Kleiman, NS; Lincoff, AM; Flaker, GC; Pieper, KS; Wilcox, RG; Berdan, LG; Lorenz, TJ; Cokkinos, DV; Simoons, ML; Boersma, E; Topol, EJ; Califf, RM; Harrington, RA
      Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes

      CIRCULATION
    88. Mark, DB; Harrington, RA; Lincoff, AM; Califf, RM; Nelson, CL; Tsiatis, AA; Buell, H; Mahaffey, KW; Davidson-Ray, L; Topol, EJ
      Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes

      CIRCULATION
    89. Newby, KH; Thompson, T; Stebbins, A; Califf, RM; Topol, EJ; Natale, A
      Sustained ventricular arrhythmias in patients receiving thrombolytic therapy - Response

      CIRCULATION
    90. Topol, EJ; Ohman, EM; Barnathan, E; Califf, RM; Lee, KL; Lincoff, AM; Ohman, EM; Scherer, J; Scott, R; Sketch, MH; Topol, EJ; Weisman, HF; Cantor, W; Evans, B; Harris, J; Kirby, J; Miller, J; Minshall, D; Oliverio, RM; Stebbins, AL; Webb, L; Wittlief, J; Topol, EJ; Lincoff, AM; Moliterno, DJ; Ivanc, T; Barnathan, E; Damaraju, L; Hadley, K; Kukulewicz, L; Scherer, J; Scott, R; Schwarz, R; Waller, M; Weisman, H; Lincoff, AM; Bachinsky, WB; Bell, C; Butler, JF; David, SW; Gibbs, K; Sakhaii, M; Hanovich, G; Herrmann, H; Hillegass, W; Kereiakes, DJ; Kiernan, J; McGrew, FA; Miklin, JS; Miller, L; Sketch, MH; Riba, A; Schreiber, TL; Smalling, RW; Talley, JD; Worley, S; Bates, ER; Hearne, S; Morris, DC; Priest, MF; Pelikan, P; Seals, AA; Smith, JE; Bach, RG; Laufer, N; Phillips, PS; McClure, R; Navetta, FI; Bhoopalam, V; Aylward, PE; Ardissino, D; Betriu, A; della Misericordi, OSM; Morocutti, G; Muller, DWM; Grinfeld, L; Cagide, A; Bode, C; Forycki, F; Lefkovits, J; Steg, G; Macaya, C; Schultheiss, HP; Eberli, F
      Trial of abciximab with and without low-dose reteplase for acute myocardial infarction

      CIRCULATION
    91. Brooks, MM; Jones, RH; Bach, RG; Chaitman, BR; Kern, MJ; Orszulak, TA; Follmann, D; Sopko, G; Blackstone, EH; Califf, RM
      Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry

      CIRCULATION
    92. Boersma, E; Pieper, KS; Steyerberg, EW; Wilcox, RG; Chang, WC; Lee, KL; Akkerhuis, KM; Harrington, RA; Deckers, JW; Armstrong, PW; Lincoff, AM; Califf, RM; Topol, EJ; Simoons, ML
      Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients

      CIRCULATION
    93. Califf, RM; Pieper, KS; Lee, KL; Van de Werf, F; Simes, RJ; Armstrong, PW; Topol, EJ
      Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial

      CIRCULATION
    94. Crenshaw, BS; Granger, CB; Birnbaum, Y; Pieper, KS; Morris, DC; Kleiman, NS; Vahanian, A; Califf, RM; Topol, EJ
      Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction

      CIRCULATION
    95. Lincoff, AM; LeNarz, LA; Despotis, GJ; Smith, PK; Booth, JE; Raymond, RE; Sapp, SK; Cabot, CF; Tcheng, JE; Califf, RM; Effron, MB; Topol, EJ
      Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials

      ANNALS OF THORACIC SURGERY
    96. Auerbach, AD; Hamel, MB; Davis, RB; Connors, AF; Regueiro, C; Desbiens, N; Goldman, L; Califf, RM; Dawson, NV; Wenger, N; Vidaillet, H; Phillips, RS
      Resource use and survival of patients hospitalized with congestive heart failure: Differences in care by specialty of the attending physician

      ANNALS OF INTERNAL MEDICINE
    97. Shah, MR; Granger, CB; Bart, BA; McMurray, JJV; Petrie, MC; Michelson, EL; Tudor, CE; Swedberg, K; Stevenson, LW; Califf, RM; Pfeffer, MA
      Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: The Study of Patients Intolerantof Converting Enzyme Inhibitors Registry

      AMERICAN JOURNAL OF MEDICINE
    98. Braunwald, E; Califf, RM; Cannon, CP; Fox, KAA; Fuster, V; Gibler, WB; Harrington, RA; King, SB; Kleiman, NS; Theroux, P; Topol, EJ; Van de Werf, F; White, HD; Willerson, JT
      Redefining medical treatment in the management of unstable angina

      AMERICAN JOURNAL OF MEDICINE
    99. Birnbaum, Y; Wagner, GS; Gates, KB; Thompson, TD; Barbash, GI; Siegel, RJ; Granger, CB; Fishbein, MC; Crenshaw, BS; Califf, RM
      Clinical and electrocardiographic variables associated with increased riskof ventricular septal defect in acute anterior myocardial infarction

      AMERICAN JOURNAL OF CARDIOLOGY
    100. O'Connor, CM; Gattis, WA; Shaw, L; Cuffe, MS; Califf, RM
      Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function

      AMERICAN JOURNAL OF CARDIOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 16:20:47